Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
jMedtech is a Singapore-headquartered medical technology and manufacturing company focused on upstream materials and process solutions for medical device makers, especially catheter and implantable device manufacturers. The company develops and supplies medical coatings, PTFE liners, multilumen and composite tubing, medical-grade extrusion products, and coating equipment, and also offers catheter CDMO and OEM support. Its portfolio includes hydrophilic lubricious coatings, phosphorylcholine-based hemocompatible coatings, heparin coatings, and precision catheter components designed to improve biocompatibility, lubricity, and device performance. jMedtech operates R&D in Singapore and has manufacturing and commercial operations in Xiamen and Shanghai, serving global medical device customers. The business appears to be a commercial-stage medtech platform company rather than a drug developer, with revenue-generating products and services already on the market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on jMedtech Coating Technologies.